Cyclerion's sGC stimulator praliciguat ameliorates NASH in rodents

DISEASE CATEGORY: Hepatic

INDICATION: Non-alcoholic steatohepatitis (NASH)

Rat and mouse studies suggest the systemic sGC stimulator praliciguat could help treat NASH. In liver samples

Read the full 232 word article

User Sign In